Pazopanib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 13 USDMF, 7 EU WC, 5 KDMF, 9 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

35 Intermediates Suppliers

35 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers, 6 FDA Orange Book, 4 Europe, 2 Canada, 12 Australia, 2 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 2 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 23 Controlled & Modified Release, 21 Direct Compression, 18 Solubilizers, 17 Disintegrants & Superdisintegrants, 16 Thickeners and Stabilizers, 13 Granulation, 11 Lubricants & Glidants, 11 Film Formers & Plasticizers, 10 Co-Processed Excipients, 8 Parenteral, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

2 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22465 / DOSAGE - TABLET;ORAL - EQ 200MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PAZOPANIB HYDROCHLORIDE(UNII: 33Y9ANM545) (PAZOPANIB - UNII:7RN5DR86CK)	PAZOPANIB	200mg

Inactive Ingredients

Ingredient Name	GlaxoSmithKline LLC	SUN PHARMACEUTICAL INDUSTRIES, INC.
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FERROSOFERRIC OXIDE(XM0M87F357)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL 400(B697894SGQ)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYSORBATE 80(6OZP39ZG8H)
POVIDONE, UNSPECIFIED(FZ989GH94E)
POVIDONES(FZ989GH94E)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Pazopanib Hydrochloride